NCT06787443

Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms

A Randomized, Placebo Controlled Clinical Study to Examine the Clinical Benefits of an Oral Product in Subjects With Menopausal Symptoms Including Vasomotor Symptoms

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 88 (actual)
• Sponsor: Olly, PBC · Industry
• Sex: Female
• Age: 40 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to assess the safety and effectiveness of a dietary supplement for symptom relief in subjects with menopausal symptoms over the course of five weeks of continuous daily use.

Conditions

• Menopausal Symptoms

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo	Eligible subjects will receive Placebo to take daily for five weeks
DIETARY_SUPPLEMENT	Dietary Supplement with Proprietary Herbal Extract Blend and GABA	Eligible subjects will receive active product to take daily for five weeks

Timeline

• Start date: 2024-05-10
• Primary completion: 2024-06-24
• Completion: 2024-06-24
• First posted: 2025-01-22
• Last updated: 2025-01-22

Locations

1 site across 1 country: United States